The Series C, backed by Eli Lilly and Bristol Myers Squibb, will advance a FAP-targeted radiotherapeutic for sarcoma and expand a pipeline of precision radioligand drugs.
The agency paused testing of RGX-121 after spinal MRI abnormalities turned up in patients treated years ago — the second clinical hold on a Regenxbio program in 2026.
Vanderbilt and TGen researchers used spatial transcriptomics on biopsy tissue to expose molecular variation within the same rejection grades — and flag who won’t respond to standard therapy.
By fusing therapeutic antibodies to albumin, researchers cut how much of the drug crosses the placenta — without sacrificing the long-lasting effect that makes these medicines useful.
The deal hands Argenx FB102, an anti-CD122 antibody with early data in vitiligo and celiac disease, deepening its push into autoimmune diseases.
BeOne gains Asian rights to Revolution’s RAS(ON) inhibitors and will test them with its own oncology drugs against some of cancer’s hardest targets.
The radiodiagnostic lets PET scans visualize tau neurofibrillary tangles — a core hallmark of Alzheimer’s — complementing existing amyloid imaging in patients being evaluated for the disease.
The Phase 3 PreVenTB study of more than 12,000 people found the vaccines helped only certain groups against certain forms of tuberculosis — underscoring how hard a better TB shot remains.
Expressable becomes the first speech-therapy provider on Amazon’s Health Benefits Connector, which matches shoppers to digital-health services their employer plans already cover.
The antibody cut new abnormal bone formation by up to 90% in a trial for fibrodysplasia ossificans progressiva — a devastating disorder in which soft tissue slowly turns to bone.
New data add to the case that simpler two-drug therapy works as well as the standard three-drug combination for people starting HIV treatment.
Vitestro’s Aletta autonomously finds a vein and draws blood in adults, with one trained phlebotomist supervising up to three machines — a possible answer to a worsening staffing shortage.